A genetically engineered, mutant human alpha-1-proteinase inhibitor is more resistant than the normal inhibitor to oxidative inactivation by chemicals, enzymes, cells, and cigarette smoke.
A genetically engineered, mutant human alpha-1-proteinase inhibitor is more resistant than the normal inhibitor to oxidative inactivation by chemicals, enzymes, cells, and cigarette smoke.
复制标题
一种基因工程突变人类 α-1-蛋白酶抑制剂比正常抑制剂更能抵抗化学物质、酶、细胞和香烟烟雾造成的氧化失活。
DOI:
10.1164/arrd.1986.133.3.353
复制
发表时间:
1986
期刊:
影响因子:
--
通讯作者:
Rosenberg,S
中科院分区:
文献类型:
--
作者:
Janoff,A;George-Nascimento,C;Rosenberg,S
Alpha-1-proteinase inhibitors (α1PI) containing methionine (Met-358) or valine (Met➝Val-358) from recombinant yeast. The pure proteins were exposed to 1 of 4 different oxidizing systems: N-chlorosuccinimide (chemical oxidation), myeloperoxidase plus peroxide and halide (enzymatic oxidation), activated neutrophils (cellular oxidation), or gas-phase cigarette smoke. The effect of these treatments on the leukocyte elastase inhibitory function of both proteins was then assessed. After brief exposures, substantial inactivation of the normal inhibitor occurred, whereas the mutant inhibitor remained fully active. More prolonged exposures led to complete inactivation of the normal protein and partial inactivation of the mutant inhibitor. These results suggest that the reactive center methionyl residue inα1PI is more rapidly affected by oxidants than are other oxidizable residues in the inhibitor; however, Met-358 is not the only residue inα1PI whose modification can lead to the inactivation of the elastase inhibitory capacity of this protein.